Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Panel Plans Oversight On Device Tax, MACRA, Trade Negotiations

Executive Summary

The US House Ways and Means Committee will focus oversight actions this Congress on Affordable Care Act issues including device tax repeal, Health and Human Services priorities – including implementation of provider payment reforms – and overseas trade negotiations, the panel agreed Feb. 14.

You may also be interested in...



Focus More On Patients, Less On Hospitals, Experts Tell Device Companies

Devices that collect and communicate patient data present opportunities for device-makers to have a closer relationship with end-users, but most device companies have little experience working directly with patients. Device firms need to close this gap by seeing the patients who use their devices as their primary customers, rather than just focusing on intermediaries like doctors, hospitals, and payers, industry experts tell Medtech Insight.

House Ways And Means Committee Membership, 115th Congress

The chart below displays the updated membership of the committee, which has important oversight on health and tax policy matters. It specifies which members sit on the Health Subcommittee.

Trump Dumps Industry-Supported Trans-Pacific Partnership

In an executive memorandum, President Trump formally pulled the US out of the Trans-Pacific Partnership (TPP) trade agreement that had been negotiated with 11 other countries and strongly supported by the device industry. Medtech industry groups tried to put a good face on things, saying they look forward to working with the new administration on bilaterial agreements to further open markets in Asia and elsewhere.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT104452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel